Nautilus Biotechnology, Inc. - 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the 2024 Annual Meeting of Stockholders held by Nautilus Biotechnology, Inc. on June 13, 2024. The company is an emerging growth company incorporated in Delaware, with its common stock (NAUT) trading on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
As of the record date (April 16, 2024), there were 125,265,015 shares outstanding. 105,300,784 shares were represented at the meeting. The following matters were voted upon:
- Election of Class III Directors: All three nominees were elected to serve until the 2027 annual meeting.
- Ratification of Independent Auditor: The appointment of PricewaterhouseCoopers LLP for the fiscal year ending December 31, 2024, was ratified.
| Nominee / Matter | Votes For | Votes Against / Withheld | Abstentions / Non-Votes |
|---|---|---|---|
| Class III Director: Melissa Epperly | 92,055,005 | 674,206 (Withheld) | 12,571,573 (Broker Non-Votes) |
| Class III Director: Matthew L. Posard | 90,642,659 | 2,086,552 (Withheld) | 12,571,573 (Broker Non-Votes) |
| Class III Director: Karen Akinsanya | 89,933,948 | 2,795,263 (Withheld) | 12,571,573 (Broker Non-Votes) |
| Ratification of PricewaterhouseCoopers LLP | 105,058,709 | 172,887 (Against) | 69,188 (Abstentions) |
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the total number of shares outstanding and the percentage of shares represented at the annual meeting.
- Confirm the tenure of the newly elected Class III directors (until 2027).
- Review the full proxy statement for details on the significant number of broker non-votes (approx. 12.5 million) regarding director elections.
- Check subsequent filings for the company's financial performance, as this 8-K contains no financial data.